24 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
over responsibility for product supply. We currently do not have insurance coverage to compensate us for such business interruptions. Our contract … strategic risk exposure, including risks associated with cybersecurity and data protection, and our audit committee has the responsibility to consider
8-K
EX-1.1
MIRA
Mira Pharmaceuticals Inc
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
Duties. The Company acknowledges and agrees that the Underwriters’ responsibility to the Company is solely contractual in nature and that none
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
take responsibility for any other information others may give you. Neither we nor any of the selling stockholders are making an offer to sell … with commercial product may lead to adverse consequences, including the right of partners to take over responsibility for product supply. We
424B1
p2wp4
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-99.1
72m51g1nl9ra3
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.4
zg319xw4wa3cq on3
29 Jun 23
IPO registration
4:39pm
S-1
bxak1o0
29 Jun 23
IPO registration
4:39pm
S-1
EX-3.2
9ct a0pu5bl
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.3
7lhtfl
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.1
rl9t 30vd3ugsga4
29 Jun 23
IPO registration
4:39pm
S-1
EX-14.1
6jj0jdv
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-99.3
kea9acm
8 Jun 23
Draft registration statement (amended)
12:00am